BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28118820)

  • 1. Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study.
    Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
    BMC Cancer; 2017 Jan; 17(1):72. PubMed ID: 28118820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
    Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
    Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
    Bogina G; Munari E; Brunelli M; Bortesi L; Marconi M; Sommaggio M; Lunardi G; Gori S; Massocco A; Pegoraro MC; Zamboni G
    Histopathology; 2016 Feb; 68(3):422-32. PubMed ID: 26114478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
    Kelten Talu C; Savli TC; Huq GE; Leblebici C
    Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature.
    Rovera F; Lavazza M; La Rosa S; Fachinetti A; Chiappa C; Marelli M; Sessa F; Giardina G; Gueli R; Dionigi G; Rausei S; Boni L; Dionigi R
    Int J Surg; 2013; 11 Suppl 1():S79-83. PubMed ID: 24380560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA; Chesney T; Elser C; Mulligan AM; McCready DR; Escallon J
    Eur J Surg Oncol; 2015 May; 41(5):625-34. PubMed ID: 25727372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
    Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
    Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression and prognostic significance of HIF-1α and VEGF-C in neuroendocrine breast cancer.
    Marton I; Knezevic F; Ramic S; Milosevic M; Tomas D
    Anticancer Res; 2012 Dec; 32(12):5227-32. PubMed ID: 23225420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
    Luhtala S; Staff S; Tanner M; Isola J
    Tumour Biol; 2016 Jul; 37(7):9813-23. PubMed ID: 26810187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma.
    Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY
    Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
    Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
    J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
    Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.
    Tsuchiya B; Iwaya K; Kohno N; Kawate T; Akahoshi T; Matsubara O; Mukai K
    Histopathology; 2012 Jul; 61(1):69-77. PubMed ID: 22385318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary neuroendocrine carcinomas of the breast and neuroendocrine differentiated breast cancers: Relationship between histopathological and radiological features.
    Kayadibi Y; Erginoz E; Cavus GH; Kurt SA; Ozturk T; Velidedeoglu M
    Eur J Radiol; 2022 Feb; 147():110148. PubMed ID: 35007984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine breast carcinoma: a rare but challenging entity.
    Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
    Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors.
    Arnason T; Sapp HL; Barnes PJ; Drewniak M; Abdolell M; Rayson D
    Neuroendocrinology; 2011; 93(4):249-58. PubMed ID: 21487213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.